Presence of three dengue serotypes in Ouagadougou (Burkina Faso): research and public health implications

被引:64
作者
Ridde, Valery [1 ,2 ]
Agier, Isabelle [2 ]
Bonnet, Emmanuel [3 ]
Carabali, Mabel [4 ]
Dabire, Kounbobr Roch [5 ]
Fournet, Florence [6 ]
Ly, Antarou [7 ]
Meda, Ivlabehire Bertrand [7 ]
Parra, Beatriz [8 ]
机构
[1] Univ Montreal, Sch Publ Hlth ESPUM, Dept Social & Prevent Med, Montreal, PQ, Canada
[2] Univ Montreal, Publ Hlth Res Inst IRSPUM, Pavillon 7101 Ave Parc,POB 6128,Ctr Ville Stn, Montreal, PQ, Canada
[3] Univ Caen Basse Normandie, Identites & Differenciat Environm Espaces & Socie, Caen, France
[4] SNU Res Pk, Dengue Vaccine Initiat, Int Vaccine Inst, 1 Gwanak Ro, Seoul 151742, South Korea
[5] IRSS, BP 545, Bobo Dioulasso, Burkina Faso
[6] IRD, Unite Malad Infect & Vecteurs Ecol Genet Evolut &, BP 171, Bobo Dioulasso, Burkina Faso
[7] IRSS, 03 BP, Ouagadougou 7192, Burkina Faso
[8] Univ Valle, Dept Microbiol, Grp Virus Emergentes & Enfermedad, Cali, Colombia
基金
加拿大健康研究院;
关键词
Dengue; Fever; Acute febrile non-malaria cases; Burkina Faso; Aedes; Health system; Cost; Mobility; CONTROL INTERVENTIONS; CHIKUNGUNYA VIRUS; HEMORRHAGIC-FEVER; AEDES-ALBOPICTUS; WEST-AFRICA; MALARIA; INFECTION; BURDEN; CAMBODIA; COST;
D O I
10.1186/s40249-016-0120-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The significant malaria burden in Africa has often eclipsed other febrile illnesses. Burkina Faso's first dengue epidemic occurred in 1925 and the most recent in 2013. Yet there is still very little known about dengue prevalence, its vector proliferation, and its poverty and equity impacts. Methods: An exploratory cross-sectional survey was performed from December 2013 to January 2014. Six primary healthcare centers in Ouagadougou were selected based on previously reported presence of Flavivirus. All patients consulting with fever or having had fever within the previous week and with a negative rapid diagnostic test (RDT) for malaria were invited to participate. Sociodemographic data, healthcare use and expenses, mobility, health-related status, and vector control practices were captured using a questionnaire. Blood samples of every eligible subject were obtained through finger pricks during the survey for dengue RDT using SD BIOLINE Dengue Duo (NS1Ag and IgG/IgM)(R) and to obtain blood spots for reverse transcription polymerase chain reaction (RT-PCR) analysis. In a sample of randomly selected yards and those of patients, potential Aedes breeding sites were found and described. Larvae were collected and brought to the laboratory to monitor the emergence of adults and identify the species. Results: Of the 379 subjects, 8.7 % (33/379) had positive RDTs for dengue. Following the 2009 WHO classification, 38.3 % (145/379) had presumptive, probable, or confirmed dengue, based on either clinical symptoms or laboratory testing. Of 60 samples tested by RT-PCR (33 from the positive tests and 27 from the subsample of negatives), 15 were positive. The serotypes observed were DENV2, DENV3, and DENV4. Odds of dengue infection in 15-to-20-year-olds and persons over 50 years were 4.0 (CI 95 %: 1.0-15.6) and 7.7 (CI 95 %: 1.6-37.1) times higher, respectively, than in children under five. Average total spending for a dengue episode was 13 771 FCFA [1 300-67 300 FCFA] (1$US = 478 FCFA). On average, 2.6 breeding sites were found per yard. Potential Aedes breeding sites were found near 71.4 % (21/28) of patients, but no adult Aedes were found. The most frequently identified potential breeding sites were water storage containers (45.2 %). Most specimens collected in yards were Culex (97.9 %). Conclusions: The scientific community, public health authorities, and health workers should consider dengue as a possible cause of febrile illness in Burkina Faso.
引用
收藏
页数:13
相关论文
共 54 条
  • [1] Dengue Virus Infection in Africa
    Amarasinghe, Ananda
    Kuritsky, Joel N.
    Letson, G. William
    Margolis, Harold S.
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (08) : 1349 - 1354
  • [2] [Anonymous], 2014, WHO AFR HLTH OBS KNO
  • [3] [Anonymous], PHYS REV E, DOI DOI 10.1103/PHYSREVE.84.011901
  • [4] [Anonymous], 2014, HLTH PEOPL WHAT WORK
  • [5] [Anonymous], 2009, DENGUE GUIDELINES DI, DOI DOI 10.1176/PN.41.1.0029B
  • [6] Cost and disease burden of Dengue in Cambodia
    Beaute, Julien
    Vong, Sirenda
    [J]. BMC PUBLIC HEALTH, 2010, 10 : 521
  • [7] The global distribution and burden of dengue
    Bhatt, Samir
    Gething, Peter W.
    Brady, Oliver J.
    Messina, Jane P.
    Farlow, Andrew W.
    Moyes, Catherine L.
    Drake, John M.
    Brownstein, John S.
    Hoen, Anne G.
    Sankoh, Osman
    Myers, Monica F.
    George, Dylan B.
    Jaenisch, Thomas
    Wint, G. R. William
    Simmons, Cameron P.
    Scott, Thomas W.
    Farrar, Jeremy J.
    Hay, Simon I.
    [J]. NATURE, 2013, 496 (7446) : 504 - 507
  • [8] African genetic ancestry is associated with a protective effect on Dengue severity in colombian populations
    Camilo Chacon-Duque, Juan
    Adhikari, Kaustubh
    Avendano, Efren
    Campo, Omer
    Ramirez, Ruth
    Rojas, Winston
    Ruiz-Linares, Andres
    Nelly Restrepo, Berta
    Bedoya, Gabriel
    [J]. INFECTION GENETICS AND EVOLUTION, 2014, 27 : 89 - 95
  • [9] Recent Introduction and Rapid Dissemination of Chikungunya Virus and Dengue Virus Serotype 2 Associated With Human and Mosquito Coinfections in Gabon, Central Africa
    Caron, Melanie
    Paupy, Christophe
    Grard, Gilda
    Becquart, Pierre
    Mombo, Illich
    Nso, Branly Bikie Bi
    Kassa, Fabrice Kassa
    Nkoghe, Dieudonne
    Leroy, Eric Maurice
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) : E45 - E53
  • [10] Human genetic determinants of dengue virus susceptibility
    Coffey, Lark L.
    Mertens, Eva
    Brehin, Anne-Claire
    Fernandez-Garcia, Maria Dolores
    Amara, Ali
    Despres, Philippe
    Sakuntabhai, Anavaj
    [J]. MICROBES AND INFECTION, 2009, 11 (02) : 143 - 156